Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas Meeting Abstract
| Authors: | Bush, N. A. O.; Yu, Y.; Villanueva-Meyer, J.; Grimmer, M.; Hilz, S.; Solomon, D.; Choi, S.; Mazor, T.; Hong, C.; Shai, A.; Phillips, J. J.; McDermott, M.; Haas-Kogan, D. A.; Taylor, J.; Butowski, N. A.; Clarke, J.; Berger, M.; Molinaro, A.; Chang, S. M.; Costello, J. |
| Abstract Title: | Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 105s |
| Language: | English |
| ACCESSION: | WOS:000560368301201 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.2506 |
| Notes: | Meeting Abstract: 2506 -- Source: Wos |
